D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Total Liabilities
myr656.9m
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
33%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Total Liabilities
myr36.2m
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
15%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Total Liabilities
myr204.3m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
8%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Total Liabilities
myr62.3m
CAGR 3-Years
2%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Total Liabilities
myr145.5m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
6%
K
Kotra Industries Bhd
KLSE:KOTRA
Total Liabilities
myr58.9m
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
-9%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Total Liabilities?
Total Liabilities
656.9m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Total Liabilities amounts to 656.9m MYR.

What is Duopharma Biotech Bhd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
33%

Over the last year, the Total Liabilities growth was -7%. The average annual Total Liabilities growth rates for Duopharma Biotech Bhd have been 5% over the past three years , 10% over the past five years , and 33% over the past ten years .

Back to Top